Havens JP - Search Results

1

HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.

Scarsi KK, Havens JP, Podany AT, Avedissian SN, Fletcher CV. Scarsi KK, et al. Among authors: havens jp. Drugs. 2020 Nov;80(16):1649-1676. doi: 10.1007/s40265-020-01379-9. Drugs. 2020. PMID: 32860583 Free PMC article. Review.

2

Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide.

Podany AT, Bares SH, Havens J, Dyavar SR, O'Neill J, Lee S, Fletcher CV, Swindells S, Scarsi KK. Podany AT, et al. AIDS. 2018 Mar 27;32(6):761-765. doi: 10.1097/QAD.0000000000001744. AIDS. 2018. PMID: 29334548 Free PMC article.

3

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction.

Lee SS, Havens JP, Sayles HR, O'Neill JL, Podany AT, Swindells S, Scarsi KK, Bares SH. Lee SS, et al. Among authors: havens jp. BMC Infect Dis. 2018 Jul 6;18(1):310. doi: 10.1186/s12879-018-3226-2. BMC Infect Dis. 2018. PMID: 29980192 Free PMC article.

4

Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.

Broekhuis JM, Scarsi KK, Sayles HR, Klepser DG, Havens JP, Swindells S, Bares SH. Broekhuis JM, et al. Among authors: havens jp. PLoS One. 2018 Nov 14;13(11):e0207372. doi: 10.1371/journal.pone.0207372. eCollection 2018. PLoS One. 2018. PMID: 30427912 Free PMC article.

5

Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States.

Havens JP, Scarsi KK, Sayles H, Klepser DG, Swindells S, Bares SH. Havens JP, et al. Open Forum Infect Dis. 2019 Oct 1;6(10):ofz365. doi: 10.1093/ofid/ofz365. Open Forum Infect Dis. 2019. PMID: 31412131 Free PMC article.

6

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.

Havens JP, Podany AT, Scarsi KK, Fletcher CV. Havens JP, et al. Clin Pharmacokinet. 2020 Feb;59(2):137-154. doi: 10.1007/s40262-019-00830-9. Clin Pharmacokinet. 2020. PMID: 31679131 Free PMC article. Review.

7

Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy.

Cirrincione LR, Podany AT, Havens JP, Bares SH, Dyavar SR, Gwon Y, Johnson TM, Amoura NJ, Fletcher CV, Scarsi KK. Cirrincione LR, et al. Among authors: havens jp. J Antimicrob Chemother. 2020 May 1;75(5):1242-1249. doi: 10.1093/jac/dkaa016. J Antimicrob Chemother. 2020. PMID: 32065631 Free PMC article. Clinical Trial.

8

Response to Dong et al.

Havens JP, Scarsi KK, Sayles H, Klepser DG, Swindells S, Bares SH. Havens JP, et al. Open Forum Infect Dis. 2020 Jan 27;7(2):ofaa032. doi: 10.1093/ofid/ofaa032. eCollection 2020 Feb. Open Forum Infect Dis. 2020. PMID: 32099845 Free PMC article. No abstract available.

9

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study.

Havens JP, Bares SH, Lyden E, Podany AT, Scarsi KK, Fadul N, Swindells S. Havens JP, et al. Open Forum Infect Dis. 2023 Feb 12;10(3):ofad080. doi: 10.1093/ofid/ofad080. eCollection 2023 Mar. Open Forum Infect Dis. 2023. PMID: 36910693 Free PMC article.

10

Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-Infection.

Havens JP, Regan NN, Bares SH. Havens JP, et al. Am J Case Rep. 2020 Jun 4;21:e923326. doi: 10.12659/AJCR.923326. Am J Case Rep. 2020. PMID: 32493896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page